株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

連鎖球菌感染症:世界の治験動向

Streptococcal Infections Global Clinical Trials Review, H2, 2018

発行 GlobalData 商品コード 721717
出版日 ページ情報 英文 134 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.74円で換算しております。
Back to Top
連鎖球菌感染症:世界の治験動向 Streptococcal Infections Global Clinical Trials Review, H2, 2018
出版日: 2018年08月31日 ページ情報: 英文 134 Pages
概要

当レポートでは、連鎖球菌感染症治療薬の治験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、治験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

当レポートの概要

調査範囲

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:感染症治療薬の治験における連鎖球菌感染症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:感染症治療薬の治験における連鎖球菌感染症の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

連鎖球菌感染症治療薬の治験に携わっている主要企業

有望な薬剤

治験プロファイルの概要

付録

図表

List of Tables

  • Streptococcal Infections Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Streptococcal Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Streptococcal Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Streptococcal Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Streptococcal Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
  • Streptococcal Infections Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Streptococcal Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
  • Streptococcal Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
  • Proportion of Streptococcal Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 17
  • Streptococcal Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
  • Streptococcal Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Proportion of Streptococcal Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 22
  • Streptococcal Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
  • Streptococcal Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
  • Streptococcal Infections Therapeutics, Global, Clinical Trials by Phase, 2018* 25
  • Streptococcal Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
  • Streptococcal Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
  • Streptococcal Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
  • Streptococcal Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
  • Streptococcal Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
  • Streptococcal Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
  • Streptococcal Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
  • Streptococcal Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures

  • Streptococcal Infections Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Streptococcal Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Streptococcal Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Streptococcal Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Streptococcal Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
  • Streptococcal Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
  • Streptococcal Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
  • Streptococcal Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
  • Proportion of Streptococcal Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
  • Streptococcal Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
  • Streptococcal Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
  • Proportion of Streptococcal Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 21
  • Streptococcal Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
  • Streptococcal Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
  • Streptococcal Infections Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
  • Streptococcal Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
  • Streptococcal Infections Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
  • Streptococcal Infections Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
  • Streptococcal Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
  • Streptococcal Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
  • Streptococcal Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
  • Streptococcal Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
  • Streptococcal Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
  • GlobalData Methodology 133
目次
Product Code: GDHC5189CTIDB

GlobalData's clinical trial report, "Streptococcal Infections Global Clinical Trials Review, H2, 2018" provides an overview of Streptococcal Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Streptococcal Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Streptococcal Infections to Infectious Disease Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Streptococcal Infections to Infectious Disease Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 23
  • Clinical Trials in E7 Countries by Trial Status 24
  • Clinical Trials by Phase 25
  • In Progress Trials by Phase 26
  • Clinical Trials by Trial Status 27
  • Clinical Trials by End Point Status 29
  • Subjects Recruited Over a Period of Time 30
  • Clinical Trials by Sponsor Type 31
  • Prominent Sponsors 32
  • Top Companies Participating in Streptococcal Infections Therapeutics Clinical Trials 34
  • Prominent Drugs 36
  • Clinical Trial Profile Snapshots 37

Appendix 132

  • Abbreviations 132
  • Definitions 132
  • Research Methodology 133
  • Secondary Research 133
  • About GlobalData 133
  • Contact Us 134
  • Disclaimer 134
  • Source 134
Back to Top